Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianhua Qingke tablets for pediatric Mycoplasma pneumonia
ChiCTR2300078209Phase 4Not yet recruiting
- Sponsor
- Hebei Yiling Hospital
- Start
- Dec 2023
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Lianhua Qingke in Mycoplasmal pneumonia (2 arms), sponsored by Hebei Yiling Hospital. Primary endpoint: Relief rate of main symptoms. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
Lianhua Qingke
03
Conditions
Mycoplasmal pneumonia
Beyond the preview
Go deeper on ChiCTR2300078209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078209.